MORU-VIRATEN BERNA VACCINE
MORU-VIRATEN BERNA VACCINE
Discontinued
DIN Number
02211017
Drug Class
Human
Market Date
Mar 7, 1996
Company
HC
swiss serum and vaccine institute berne
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02211017
AIG Number0328480001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BD53 MORBILLI, COMB. WITH RUBELLA, LIVE ATTENUATED
Product Specifications
Dosage FormPowder For Solution
,
Liquid
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
MEASLES VIRUS VACCINE LIVE ATTENUATEDActive
Strength: 1 DOSE / KIT
Monograph: MEASLES VIRUS VACCINE LIVE ATTENUATED
RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)Active
Strength: 1 DOSE / KIT
Monograph: RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)
WATERActive
Strength: .5 ML / KIT
Monograph: WATER